Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us ![]()
About
Not Confirmed
Not Confirmed
10-12 December, 2025
Cosmoprof IndiaCosmoprof India
Not Confirmed
Not Confirmed
04-06 December, 2025
Not Confirmed
Not Confirmed
05-09 December, 2025
List your booth number for exhibitions, ask us
CONTACT DETAILS




Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
Industry Trade Show
Not Confirmed
10-12 December, 2025
Cosmoprof IndiaCosmoprof India
Industry Trade Show
Not Confirmed
04-06 December, 2025
Industry Trade Show
Not Confirmed
05-09 December, 2025
Digital content

08 Mar 2021
// BUSINESSWIRE
https://www.businesswire.com/news/home/20210308005285/en/ImmunityBio-and-NantKwest-Begin-Dosing-Participants-in-Global-Trials-for-Novel-COVID-19-Vaccine-Subcutaneous-Route-in-South-Africa-Oral-and-Sublingual-in-the-U.S.

11 Feb 2021
// BUSINESSWIRE
https://www.businesswire.com/news/home/20210211005960/en/ImmunityBio-and-NantKwest-Announce-FDA-Authorization-to-Study-hAd5-T-Cell-COVID-19-Vaccine-for-Combination-of-Subcutaneous-Oral-and-Sublingual-Boost-to-Induce-T-Cell-Mucosal-and-Antibody-Immunity

13 Jan 2021
// PRESS RELEASE
https://nantkwest.com/nantkwest-immunitybio-announce-positive-interim-data-on-survival-rates-in-metastatic-pancreatic-cancer-trials/

22 Dec 2020
// BUSINESSWIRE

22 Dec 2020
// BUSINESSWIRE
https://www.businesswire.com/news/home/20201222005352/en/CytRx-Comments-on-Proposed-Combination-of-ImmunityBio-and-NantKwest

22 Dec 2020
// BUSINESSWIRE
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE